Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic HSCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Not applicableStudy completedNCT03915249
What this trial is testing

Physical Functions in Allogeneic-HSCT Candidates

Who this might be right for
Stem Cell Transplantation
Gazi University 49
Not applicableLooking for participantsNCT07483385
What this trial is testing

Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell TransplantationHematologic Disorders
The General Hospital of Western Theater Command 45
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Not applicableUnknownNCT04349540
What this trial is testing

Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19

Who this might be right for
COVID19
Great Ormond Street Hospital for Children NHS Foundation Trust 40
Not applicableLooking for participantsNCT06708130
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital 3,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Testing effectiveness (Phase 2)Study completedNCT00721214
What this trial is testing

5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Virginia Commonwealth University 16
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07774377
What this trial is testing

Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic LeukemiaT-Cell Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 132
Not applicableEnded earlyNCT01326728
What this trial is testing

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Early research (Phase 1)Study completedNCT02472392
What this trial is testing

Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma

Who this might be right for
EWINGS SARCOMA
University of Louisville 10
Not applicableLooking for participantsNCT07341698
What this trial is testing

Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Rigshospitalet, Denmark 110
Testing effectiveness (Phase 2)WithdrawnNCT00101140
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Adult Acute Erythroid LeukemiaAdult Acute Monoblastic and Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Post-approval studies (Phase 4)Study completedNCT00361140
What this trial is testing

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Large-scale testing (Phase 3)Not Yet RecruitingNCT06613035
What this trial is testing

Twice-per-weekSelinexor, 2 Days Melphalan

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 126
Testing effectiveness (Phase 2)Study completedNCT00020176
What this trial is testing

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Next Page